Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Aadi Bioscience Inc
3350Current price
1.96 EUR
-0.02 EUR (-1.01%)
Last closed
2.17 USD
Company
aadibio.com
ISIN
US00032Q1040
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
52 375 724 USD
Yield for 12 month
-54.51 %
1Y
3Y
5Y
10Y
15Y
3350
Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa. The company is also involved in evaluating FYARRO in cancers, including indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California. Address: 17383 Sunset Boulevard, Pacific Palisades, CA, United States, 90272
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1.88 USDP/E ratio
–Dividend Yield
–Current Year
+24 354 000 USD
Last Year
+15 216 000 USD
Current Quarter
+7 212 000 USD
Last Quarter
+6 179 000 USD
Current Year
+21 545 000 USD
Last Year
+13 881 000 USD
Current Quarter
+7 212 000 USD
Last Quarter
+5 401 000 USD
Key Figures 3350
1 year
3 years
5 years
10 years
EBITDA
-70 472 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-34.93 %
PEG Ratio
–
Return On Equity TTM
-62.26 %
Wall Street Target Price
1.88 USD
Revenue TTM
23 817 000 USD
Book Value
4.28 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-0.4 %
Dividend Yield
–
Gross Profit TTM
-18 781 000 USD
Earnings per share
-2.28 USD
Diluted Eps TTM
-2.28 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-274.77 %
Dividend Analytics 3350
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 3350
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:15
Payout Ratio
–
Last Split Date
27.08.2021
Dividend Date
–
Stock Valuation 3350
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
3.4826
Price Sales TTM
2.1991
Enterprise Value EBITDA
-0.6156
Price Book MRQ
0.7587
Financials 3350
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 3350
For 52 weeks
1.21 USD
5.7 USD
50 Day MA
1.95 USD
Shares Short Prior Month
352 158
200 Day MA
1.83 USD
Short Ratio
2.24
Shares Short
283 524
Short Percent
1.7 %
BeatStart